Millipore Sigma Vibrant Logo

MABF106 Anti-Viperin Antibody, clone MaP.VIP

View Products on Sigmaaldrich.com
MABF106
100 µg  
Retrieving price...
Price could not be retrieved
Minimum Quantity is a multiple of
Maximum Quantity is
Upon Order Completion More Information
You Saved ()
 
Request Pricing
Limited Availability
Limited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      Special Offers

       

      Contact Customer Service

      Overview

      Replacement Information

      Key Spec Table

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      M, H, RWB, IHC, FC, IP, ICCMPurifiedMonoclonal Antibody
      Description
      Catalogue NumberMABF106
      DescriptionAnti-Viperin Antibody, clone MaP.VIP
      Alternate Names
      • Radical S-adenosyl methionine domain-containing protein 2
      • Cytomegalovirus-induced gene 5 protein
      • Viperin
      • Virus inhibitory protein,endoplasmic reticulum-associated, interferon-inducible
      Background InformationVirus inhibitory protein endoplasmic reticulum-associated interferon-inducible (Viperin) belongs to the RSAD2 family and is highly inducible by both type I and type II interferons, but little or no induction is observed in moncytic cell lines. Studies suggest that viperin is involved in host antiviral response, as viperin induction is observed from viral infections. Research also reveals that viperin inhibits influenza replication by disrupting its release from the plasmic membrane through the altering of plasma membrane fluidity by affecting formation of lipid rafts. Lipid rafts are known detergent-resistant microdomian sites for influenza budding.
      References
      Product Information
      FormatPurified
      HS Code3002 15 90
      Control
      • Mouse macrophage stimulated with IFN gamma and LPS
      PresentationPurified mouse monoclonal IgG2aκ in buffer containing 0.1 M Tris-Glycine (pH 7.4), 150 mM NaCl with 0.05% sodium azide.
      Quality LevelMQ100
      Applications
      ApplicationAnti-Viperin Antibody, clone MaP.VIP detects level of Viperin & has been published & validated for use in WB, IH, FC, IP & IC.
      Key Applications
      • Western Blotting
      • Immunohistochemistry
      • Flow Cytometry
      • Immunoprecipitation
      • Immunocytochemistry
      Application NotesImmunohistochemistry Analysis: A 1:500-1:1,000 dilution from a representative lot detected Viperin in human colon and rat liver tissues.

      Immunoprecipitation Analysis: A representative lot was used by an independent laboratory in HepG2 cell lysate (Hinson, E., et al. (2008). JBC. 284(7):4705–4712).

      Flow Cytometry Analysis: A representative lot was used by an independent laboratory in mouse liver, spleen, lung, and lymph node cells (Hinson, E., et al. (2010). J. Immunol. 184:5723-5731).

      Immunocytochemistry Analysis: A representative lot was used by an independent laboratory in mouse spleen cells (Hinson, E., et al. (2010). J. Immunol. 184:5723-5731).
      Biological Information
      ImmunogenRecombinant protein corresponding to human Viperin.
      CloneMaP.VIP
      ConcentrationPlease refer to the Certificate of Analysis for the lot-specific concentration.
      HostMouse
      IsotypeIgG2aκ
      Species Reactivity
      • Mouse
      • Human
      • Rat
      Antibody TypeMonoclonal Antibody
      Entrez Gene Number
      Gene Symbol
      • RSAD2
      • CIG5
      Purification MethodProtein G Purified
      UniProt Number
      UniProt SummaryFUNCTION: Involved in antiviral defense. May impair virus budding by disrupting lipid rafts at the plasma membrane, a feature which is essential for the budding process of many viruses. Acts through binding with and inactivating FPPS, an enzyme involved in synthesis of cholesterol, farnesylated and geranylated proteins, ubiquinones dolichol and heme. Plays a major role in the cell antiviral state induced by type I and type II interferon. Displays antiviral effect against HIV-1 virus, hepatitis C virus, human cytomegalovirus, and aphaviruses, but not vesiculovirus. COFACTOR: Binds 1 4Fe-4S cluster. The cluster is coordinated with 3 cysteines and an exchangeable S-adenosyl-L-methionine (By similarity).

      SUBUNIT STRUCTURE: Interacts with FPPS.

      SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Peripheral membrane protein; Cytoplasmic side. Golgi apparatus. Note: Probably associates with the cytosolic side of the endoplasmic reticulum. Infection with human cytomegalovirus (HCMV) causes relocation to the Golgi apparatus and to cytoplasmic vacuoles which also contain HCMV proteins glycoprotein B and pp28.

      INDUCTION: By interferon type I, type II and bacterial lipopolysaccharides (LPS). Little or no induction by IFNG/IFN-gamma is observed in monocytic cell lines. Induced by infection with human cytomegalovirus (HMCV), hepatitis C virus, yellow fever virus and Sendai virus, presumably through type I interferon pathway.

      MISCELLANEOUS: Up-regulated in atherosclerosis. Latent viruses like HCMV may be involved in atherogenesis by initiating local inflammation. This may induce up-regulation of antiviral gene RSAD2, which modulates lipids synthesis, and thus could play a role in abnormal lipid accumulation leading to atherosclerosis.

      SEQUENCE SIMILARITIES: Belongs to the RSAD2 family.
      Molecular Weight~42 kDa observed
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceEvaluated by Western Blot in mouse macrophage stimulated with IFN gamma and LPS.

      Western Blot Analysis: 1 µg/mL of this antibody detected Viperin in 10 µg of mouse macrophage stimulated with IFN gamma and LPS.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at 2-8°C from date of receipt.
      Packaging Information
      Material Size100 µg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalogue Number GTIN
      MABF106 04053252535581

      Documentation

      Anti-Viperin Antibody, clone MaP.VIP SDS

      Title

      Safety Data Sheet (SDS) 

      Anti-Viperin Antibody, clone MaP.VIP Certificates of Analysis

      TitleLot Number
      Anti-Viperin, clone MaP.VIP 2478928
      Anti-Viperin, clone MaP.VIP 2472975
      Anti-Viperin, clone MaP.VIP - 2388997 2388997
      Anti-Viperin, clone MaP.VIP - 2139410 2139410
      Anti-Viperin, clone MaP.VIP - 2197245 2197245
      Anti-Viperin, clone MaP.VIP - 2225195 2225195
      Anti-Viperin, clone MaP.VIP - 2295502 2295502
      Anti-Viperin, clone MaP.VIP - 3060434 3060434
      Anti-Viperin, clone MaP.VIP - 3172460 3172460
      Anti-Viperin, clone MaP.VIP - 3211900 3211900

      References

      Reference overviewPub Med ID
      AIM2 Drives Joint Inflammation in a Self-DNA Triggered Model of Chronic Polyarthritis.
      Jakobs, C; Perner, S; Hornung, V
      PloS one  10  e0131702  2015

      Show Abstract
      26114879 26114879
      Viperin is highly induced in neutrophils and macrophages during acute and chronic lymphocytic choriomeningitis virus infection.
      Hinson, Ella R, et al.
      J. Immunol., 184: 5723-31 (2010)  2010

      Show Abstract
      20410488 20410488
      The N-terminal amphipathic alpha-helix of viperin mediates localization to the cytosolic face of the endoplasmic reticulum and inhibits protein secretion.
      Hinson, Ella R and Cresswell, Peter
      J. Biol. Chem., 284: 4705-12 (2009)  2009

      Show Abstract
      19074433 19074433